Characterization of the intestinal microbial profile in mild cognitive impairment and Alzheimer's disease

Martin Medrano1, Mar Pacheco-Herrero2, Zunilda Borges3

  • 1Pontificia Universidad Católica Madre y Maestra, Vicerrectoría de Investigación e Innovación y Escuela de Medicina, Santiago de los Caballeros, República Dominicana.

Insights

Gut microbiota alterations are linked to Alzheimer's disease (AD) and mild cognitive impairment (MCI) in the Dominican Republic. Specific bacterial changes were observed, influenced by diet, in this Hispanic population.

Area of Science:

  • Neuroscience
  • Microbiology
  • Genetics

Background:

  • Alzheimer's disease (AD) and mild cognitive impairment (MCI) are leading causes of dementia, with increasing prevalence in Latin America.
  • Gut microbiota dysbiosis is implicated in neurodegeneration, yet data from Hispanic populations remain scarce.

Purpose of the Study:

  • To characterize the gut microbiota in individuals with AD, MCI, and healthy controls in the Dominican Republic.
  • To investigate associations between gut microbiota composition and clinical, demographic, and dietary factors in a Hispanic cohort.

Main Methods:

  • A prospective-translational study involving 88 participants aged 60 years and older.
  • 16S rRNA gene sequencing of stool samples analyzed using QIIME2 and R for microbial diversity, taxonomy, and differential abundance.
  • Dietary influences on gut microbiota were assessed using PERMANOVA.

Main Results:

  • No significant differences in alpha or beta diversity were found between AD, MCI, and control groups.
  • Abundance of Desulfobacterota was higher in MCI and AD groups compared to controls (p<0.05).
  • Specific genera (Bilophila, Odoribacter, Parabacteroides) increased, while others (Mitsuokella, Eubacterium ruminantium) decreased in MCI/AD. The Firmicutes/Bacteroidota ratio was lower in men with MCI. Dietary factors like mango, lettuce, and carrot influenced specific taxa.

Conclusions:

  • This study provides the first characterization of gut microbiota in AD and MCI within the Dominican Republic, revealing microbial shifts associated with cognitive impairment.
  • Findings highlight the role of regional dietary and ethnic factors in shaping the gut microbiome in this population.
  • Further longitudinal and multi-omics studies are recommended to establish causality and explore therapeutic potential.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...